TAU-MEDICAL

Our technology is a state-of-the-art treatment with a simple minimally invasive approach targeting specific areas or blood vessels within the heart valve and ventricular septum... We have been researching and developing state-of-the-art minimally invasive surgical methodologies for treating Tricuspid Valve Regurgitation (TR), Mitral Valve Regurgitation (MR), Hypertrophic Obstructive Cardiomyopathy (HOCM), and Heart arrhythmia. Our R&D centers and manufacturing facilities are located in Busan and Yangsan in Korea, and we are actively preparing for global clinical trials with top-tier cardiac clinical experts in the USA and Europe.

Also known as: Tau-Medical Inc.

Primary location: Reston United States